Fortress Biotech Liabilities 2024

Fortress Biotech Aktienanalyse

What does Fortress Biotech do?

Fortress Biotech Inc was founded in 2006 and is headquartered in New York City. The company specializes in the development of therapies for serious diseases and operates under a cooperative business model. The business model of Fortress Biotech is based on having multiple subsidiary companies under its umbrella, each focusing on specific development programs. This allows for specialized coverage of every aspect of the development process, from basic research to clinical trials to drug approval by authorities, by each subsidiary. Fortress Biotech has a total of nine subsidiary companies, each conducting its own research and development programs. These programs mainly target cancer, rare diseases, and metabolic disorders. With its various subsidiary companies, the company is able to develop and manufacture a wide range of therapeutic solutions. One of Fortress Biotech's most well-known subsidiary companies is Mustang Bio, a biotechnology company focusing on the development of immune-based therapies for cancer patients. The company has developed a promising CAR-T cell therapy that is currently being studied in clinical trials. Another subsidiary company of Fortress Biotech is Caelum Biosciences, which develops therapies for hematological diseases. The company is currently working on a promising monoclonal antibody therapy to help patients with the rare disease AL amyloidosis. In addition to its subsidiary companies, Fortress Biotech also collaborates with other companies and academic institutions to develop innovative therapies. The company has partnerships with companies such as Kadmon Holdings, Inc. and Aevi Genomic Medicine, Inc. Fortress Biotech has had an impressive growth story in recent years. Through targeted acquisitions of companies with promising product pipelines, the company has been able to rapidly progress and expand its offering of therapeutic solutions. In summary, Fortress Biotech is a promising biotechnology company specializing in the development of therapies for serious diseases. With its cooperative business model, wide range of subsidiary companies, and partnerships, the company is able to develop and bring innovative therapy solutions to market to help patients worldwide. Fortress Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Fortress Biotech's Liabilities

Fortress Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Fortress Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Fortress Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Fortress Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Fortress Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Fortress Biotech stock

What is the level of liabilities of Fortress Biotech this year?

Fortress Biotech has a debt balance of 144.98 M USD this year.

What were the liabilities of Fortress Biotech compared to the previous year?

The liabilities of Fortress Biotech have increased by -42.6% dropped compared to the previous year.

What are the consequences of high debt for investors of Fortress Biotech?

High liabilities can pose a risk for investors of Fortress Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Fortress Biotech?

Low liabilities mean that Fortress Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Fortress Biotech affect the company?

An increase in liabilities of Fortress Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Fortress Biotech affect the company?

A decrease in the liabilities of Fortress Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Fortress Biotech?

Some factors that can influence the liabilities of Fortress Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Fortress Biotech so important for investors?

The liabilities of Fortress Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Fortress Biotech take to modify the liabilities?

To change its liabilities, Fortress Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Fortress Biotech pay?

Over the past 12 months, Fortress Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fortress Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Fortress Biotech?

The current dividend yield of Fortress Biotech is .

When does Fortress Biotech pay dividends?

Fortress Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fortress Biotech?

Fortress Biotech paid dividends every year for the past 0 years.

What is the dividend of Fortress Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fortress Biotech located?

Fortress Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fortress Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fortress Biotech from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Fortress Biotech pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Fortress Biotech in the year 2023?

In the year 2023, Fortress Biotech distributed 0 USD as dividends.

In which currency does Fortress Biotech pay out the dividend?

The dividends of Fortress Biotech are distributed in USD.